Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Attention Deficit DisorderAttention Deficit Disorder With Hyperactivity
Interventions
DEVICE

2 mA transcranial direct current stimulation (tDCS)

tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 2mA condition, the investigators will assist the administration of a 2mA current stimulation from the device.

DEVICE

1 mA transcranial direct current stimulation (tDCS)

tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 1mA condition, the investigators will assist the administration of a 1mA current stimulation from the device.

DEVICE

Sham transcranial direct current stimulation (tDCS)

tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the sham condition, the investigators will assist the administration of a sham stimulation from the device.

Trial Locations (1)

02129

RECRUITING

Massachusetts General Hospital, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER